Sort by
Keyphrases
Antithrombotic Therapy
100%
Atrial Fibrillation
100%
Evidence-based Clinical Practice Guideline
100%
American College of Chest Physicians
100%
8th Edition
100%
Anticoagulation
58%
Cardioversion
50%
Oral Vitamin K Antagonists
50%
Risk Factors
33%
Warfarin
33%
Transesophageal Echocardiography
33%
Long-term Anticoagulation
33%
Paroxysmal Atrial Fibrillation
33%
Ischemic Stroke
25%
International Normalized Ratio
16%
Aspirin
16%
Vitamin K Antagonists
16%
Heparin
16%
Thrombus
16%
Low Molecular Weight Heparin
16%
Risk of Ischemic Stroke
16%
Echocardiography Guided
16%
Sinus Rhythm
16%
Electrical Cardioversion
16%
Pharmacological Cardioversion
16%
Clinical Practice Guidelines
8%
Low Risk
8%
Systemic Embolism
8%
High Risk
8%
Risky Driving
8%
Heart Failure
8%
Intermediate Risk
8%
Patient Values
8%
Type 1 Diabetes Mellitus (T1DM)
8%
Aspirin Therapy
8%
Heart Valve Prosthesis
8%
Evidence-based Guidelines
8%
Transient Ischemic Attack
8%
Left Ventricular Systolic Function
8%
Mitral Stenosis
8%
Atrial Flutter
8%
History of Hypertension
8%
Specific Types
8%
Elective Cardioversion
8%
Prosthesis Type
8%
Multiplane Transesophageal Echocardiography
8%
Therapy Decision
8%
Medicine and Dentistry
Atrial Fibrillation
100%
Antithrombotic Therapy
100%
Anticoagulation
91%
Cardioversion
75%
Vitamin K Antagonist
66%
Oral
50%
Brain Ischemia
41%
Transesophageal Echocardiography
41%
Warfarin
33%
Paroxysmal Atrial Fibrillation
33%
Acetylsalicylic Acid
25%
Heparin
16%
Thrombus
16%
Low Molecular Weight Heparin
16%
Sinus Rhythm
16%
Congestive Heart Failure
8%
Clinical Guideline
8%
Diabetes Mellitus
8%
Prosthesis
8%
Contraindication
8%
Transient Ischemic Attack
8%
Systolic Function
8%
Heart Valve Prosthesis
8%
Retinol
8%
Mitral Valve Stenosis
8%
Atrial Flutter
8%